Matters for binding determination. The Commonwealth’s determination as to all or any of the following matters is final and binding on the Participant: (a) whether activity is Eligible Pharmaceutical R&D Activity; (b) whether expenditure is Eligible Expenditure; (c) whether expenditure has been incurred in respect of the Portfolio; and (d) whether a Performance Milestone has been met.
Appears in 3 contracts
Sources: Funding Agreement (Peplin Inc), Funding Agreement (Pharmaxis Ltd.), Funding Agreement (Peplin Inc)